{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:30:09Z","timestamp":1789140609234,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100024586","name":"Human Resource Development Centre, Council of Scientific And Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","award":["2021-10212\/GENOMICS\/AD-HOC-BMS"],"award-info":[{"award-number":["2021-10212\/GENOMICS\/AD-HOC-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18264-8","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:53:44Z","timestamp":1759488824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ID8 cells manifest phenotypic plasticity and molecular heterogeneity of high-grade serous ovarian cancer in response to the local tissue niche"],"prefix":"10.1038","volume":"15","author":[{"given":"Ritika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shravan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna Balaji","family":"Agwane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul Maruti","family":"Bankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila A.","family":"Bapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"18264_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-023-01192-4","volume":"16","author":"P Kumar","year":"2023","unstructured":"Kumar, P. et al. Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. J. Ovarian Res. 16, 1 (2023).","journal-title":"J. Ovarian Res."},{"key":"18264_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00971-6","volume":"13","author":"M Govindarajan","year":"2020","unstructured":"Govindarajan, M., Wohlmuth, C., Waas, M., Bernardini, M. Q. & Kislinger, T. High-throughput approaches for precision medicine in high-grade serous ovarian cancer. J. Hematol. Oncol. 13, 1 (2020).","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"18264_CR3","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.3390\/cancers13143465","volume":"13","author":"A Saleh","year":"2021","unstructured":"Saleh, A. & Perets, R. Mutated p53 in HGSC\u2014From a common mutation to a target for therapy. Cancers 13(14), 3465 (2021).","journal-title":"Cancers"},{"key":"18264_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11912-020-00933-8","volume":"6","author":"RD Mahmood","year":"2020","unstructured":"Mahmood, R. D., Morgan, R. D., Edmondson, R. J., Clamp, A. R. & Jayson, G. C. First-line management of advanced high-grade serous ovarian cancer. Curr. Oncol. Rep. 6, 64 (2020).","journal-title":"Curr. Oncol. Rep."},{"issue":"4","key":"18264_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","volume":"21","author":"KF Roby","year":"2000","unstructured":"Roby, K. F. et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21(4), 585\u2013591 (2000).","journal-title":"Carcinogenesis"},{"key":"18264_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1158\/2767-9764.CRC-22-0017","volume":"2","author":"GM Rodriguez","year":"2022","unstructured":"Rodriguez, G. M. et al. The tumor immune profile of murine ovarian cancer models: An essential tool for ovarian cancer immunotherapy research. Cancer Res. Commun. 2, 417\u2013433 (2022).","journal-title":"Cancer Res. Commun."},{"issue":"6","key":"18264_CR7","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/S0002-9440(10)64505-1","volume":"161","author":"L Zhang","year":"2002","unstructured":"Zhang, L. et al. Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am. J. Pathol. 161(6), 2295\u20132309 (2002).","journal-title":"Am. J. Pathol."},{"issue":"2","key":"18264_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/2159-8290.CD-20-0818","volume":"11","author":"S Iyer","year":"2021","unstructured":"Iyer, S. et al. Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy. Cancer Discov. 11(2), 384\u2013407 (2021).","journal-title":"Cancer Discov."},{"issue":"12","key":"18264_CR9","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.3390\/cancers12123716","volume":"12","author":"R Hass","year":"2020","unstructured":"Hass, R., von der Ohe, J. & Ungefroren, H. Impact of the tumor microenvironment on tumor heterogeneity and consequences for cancer cell plasticity and stemness. Cancers 12(12), 3716 (2020).","journal-title":"Cancers"},{"issue":"6","key":"18264_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21(6), 341\u2013352 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"18264_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","volume":"20","author":"AC Veneziani","year":"2023","unstructured":"Veneziani, A. C. et al. Heterogeneity and treatment landscape of ovarian carcinoma. Nat. Rev. Clin. Oncol. 20(12), 820\u2013842 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"18264_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s41745-020-00174-5","volume":"100","author":"S Mukherjee","year":"2020","unstructured":"Mukherjee, S., Phadte, P., Mehrotra, M. & Ray, P. Plasticity in ovarian cancer: The molecular underpinnings and phenotypic heterogeneity. J. Indian Inst. Sci. 100(3), 537\u2013553 (2020).","journal-title":"J. Indian Inst. Sci."},{"issue":"3","key":"18264_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/jcm8030330","volume":"8","author":"SC Kamble","year":"2019","unstructured":"Kamble, S. C. et al. Clinical stratification of high-grade ovarian serous carcinoma using a panel of six biomarkers. J. Clin. Med. 8(3), 330 (2019).","journal-title":"J. Clin. Med."},{"key":"18264_CR14","doi-asserted-by":"crossref","unstructured":"Varankar, S. S. & Bapat, S. A. Migratory metrics of wound healing: A quantification approach for in vitro scratch assays. Front. Oncol. 8 (2018).","DOI":"10.3389\/fonc.2018.00633"},{"issue":"4","key":"18264_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/carcin\/bgz119","volume":"41","author":"S Varankar","year":"2019","unstructured":"Varankar, S. et al. Functional balance between Tcf21\u2013Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines. Carcinogenesis 41(4), 515\u2013526 (2019).","journal-title":"Carcinogenesis"},{"issue":"1","key":"18264_CR16","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7(1), 16878 (2017).","journal-title":"Sci. Rep."},{"issue":"43","key":"18264_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102(43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"D1","key":"18264_CR18","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2015","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44(D1), D457\u2013D462 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"18264_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"18264_CR20","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25(8), 1091\u20131093 (2009).","journal-title":"Bioinformatics"},{"issue":"2","key":"18264_CR21","doi-asserted-by":"publisher","first-page":"021001","DOI":"10.1088\/1478-3975\/aaf928","volume":"16","author":"Y Sha","year":"2019","unstructured":"Sha, Y. et al. Intermediate cell states in epithelial-to-mesenchymal transition. Phys. Biol. 16(2), 021001 (2019).","journal-title":"Phys. Biol."},{"issue":"7","key":"18264_CR22","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao, Y. R. et al. ImmuCellAI: A unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy. Adv. Sci. 7(7), 1902880 (2020).","journal-title":"Adv. Sci."},{"issue":"2","key":"18264_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ygyno.2020.11.009","volume":"160","author":"CB Morse","year":"2021","unstructured":"Morse, C. B. et al. Development of a clinically relevant ovarian cancer model incorporating surgical cytoreduction to evaluate treatment of micro-metastatic disease. Gynecol. Oncol. 160(2), 427\u2013437 (2021).","journal-title":"Gynecol. Oncol."},{"issue":"94","key":"18264_CR24","first-page":"52241","volume":"18","author":"V Menon","year":"2014","unstructured":"Menon, V., Thomas, R., Ghale, A. R., Reinhard, C. & Pruszak, J. Flow cytometry protocols for surface and intracellular antigen analyses of neural cell types. J. Vis. Exp. 18(94), 52241 (2014).","journal-title":"J. Vis. Exp."},{"issue":"2","key":"18264_CR25","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/aaf928","volume":"16","author":"Y Sha","year":"2019","unstructured":"Sha, Y. et al. Intermediate cell states in epithelial-to-mesenchymal transition. Phys. Biol. 16(2), 021001 (2019).","journal-title":"Phys. Biol."},{"issue":"1","key":"18264_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41540-023-00309-1","volume":"9","author":"S Shah","year":"2023","unstructured":"Shah, S. et al. Understanding and leveraging phenotypic plasticity during metastasis formation. npj Syst. Biol. Appl. 9(1), 48 (2023).","journal-title":"npj Syst. Biol. Appl."},{"issue":"2","key":"18264_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2018","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20(2), 69\u201384 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7702","key":"18264_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556(7702), 463\u2013468 (2018).","journal-title":"Nature"},{"issue":"19","key":"18264_CR29","doi-asserted-by":"publisher","first-page":"27067","DOI":"10.18632\/oncotarget.8166","volume":"7","author":"MK Jolly","year":"2016","unstructured":"Jolly, M. K. et al. Stability of the hybrid epithelial\/mesenchymal phenotype. Oncotarget 7(19), 27067\u201327084 (2016).","journal-title":"Oncotarget"},{"issue":"9","key":"18264_CR30","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.bbagrm.2015.07.006","volume":"1849","author":"B Kumar","year":"2015","unstructured":"Kumar, B. et al. Auto regulation of Slug mediates its activity during epithelial to mesenchymal transition. Biochimica et Biophysica Acta (BBA) Gene Regulatory Mech. 1849(9), 1209\u20131218 (2015).","journal-title":"Biochimica et Biophysica Acta (BBA) Gene Regulatory Mech."},{"issue":"12","key":"18264_CR31","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.7150\/thno.74002","volume":"12","author":"SK Paidi","year":"2022","unstructured":"Paidi, S. K. et al. Raman spectroscopy reveals phenotype switches in breast cancer metastasis. Theranostics 12(12), 5351\u20135363 (2022).","journal-title":"Theranostics"},{"issue":"52","key":"18264_CR32","doi-asserted-by":"publisher","first-page":"26835","DOI":"10.1073\/pnas.1914915116","volume":"116","author":"RL Porter","year":"2019","unstructured":"Porter, R. L. et al. Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma. Proc. Natl. Acad. Sci. USA 116(52), 26835\u201326845 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"18264_CR33","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.3390\/cancers13215355","volume":"13","author":"P Baumeister","year":"2021","unstructured":"Baumeister, P., Zhou, J., Canis, M. & Gires, O. Epithelial-to-mesenchymal transition-derived heterogeneity in head and neck squamous cell carcinomas. Cancers (Basel) 13(21), 5355\u20135365 (2021).","journal-title":"Cancers (Basel)"},{"issue":"6","key":"18264_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41588-020-0630-5","volume":"52","author":"A Jim\u00e9nez-S\u00e1nchez","year":"2020","unstructured":"Jim\u00e9nez-S\u00e1nchez, A. et al. Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy. Nat. Genet. 52(6), 582\u2013593 (2020).","journal-title":"Nat. Genet."},{"issue":"1","key":"18264_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41698-024-00640-8","volume":"8","author":"C Mateiou","year":"2024","unstructured":"Mateiou, C. et al. Spatial tumor immune microenvironment phenotypes in ovarian cancer. npj Precis. Oncol. 8(1), 148 (2024).","journal-title":"npj Precis. Oncol."},{"issue":"2","key":"18264_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","volume":"23","author":"D Yang","year":"2013","unstructured":"Yang, D. et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 23(2), 186\u2013199 (2013).","journal-title":"Cancer Cell"},{"issue":"1","key":"18264_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","volume":"123","author":"CE Ford","year":"2020","unstructured":"Ford, C. E., Werner, B., Hacker, N. F. & Warton, K. The untapped potential of ascites in ovarian cancer research and treatment. Br. J. Cancer 123(1), 9\u201316 (2020).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"18264_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41540-023-00322-4","volume":"9","author":"E Yakubovich","year":"2023","unstructured":"Yakubovich, E., Cook, D. P., Rodriguez, G. M. & Vanderhyden, B. C. Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis. npj Syst. Biol. Appl. 9(1), 1\u201317 (2023).","journal-title":"npj Syst. Biol. Appl."},{"issue":"3","key":"18264_CR39","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.18632\/oncotarget.14012","volume":"8","author":"B Zhao","year":"2016","unstructured":"Zhao, B. et al. Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. Oncotarget 8(3), 3980\u20134000 (2016).","journal-title":"Oncotarget"},{"issue":"9","key":"18264_CR40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1158\/2326-6066.CIR-16-0365","volume":"5","author":"HY Li","year":"2017","unstructured":"Li, H. Y. et al. The Tumor microenvironment regulates sensitivity of murine lung tumors to PD-1\/PD-L1 antibody blockade. Cancer Immunol. Res. 5(9), 767\u2013777 (2017).","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"18264_CR41","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1002\/ctm2.551","volume":"11","author":"S Pisano","year":"2021","unstructured":"Pisano, S. et al. Assessment of the immune landscapes of advanced ovarian cancer in an optimized in vivo model. Clin. Transl. Med. 11(10), e551 (2021).","journal-title":"Clin. Transl. Med."},{"issue":"12","key":"18264_CR42","doi-asserted-by":"publisher","first-page":"100856","DOI":"10.1016\/j.xcrm.2022.100856","volume":"3","author":"B Yang","year":"2022","unstructured":"Yang, B. et al. Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis. Cell Rep. Med. 3(12), 100856\u2013100866 (2022).","journal-title":"Cell Rep. Med."},{"issue":"5","key":"18264_CR43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","volume":"170","author":"A Jim\u00e9nez-S\u00e1nchez","year":"2017","unstructured":"Jim\u00e9nez-S\u00e1nchez, A. et al. Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient. Cell 170(5), 927\u2013938.e20 (2017).","journal-title":"Cell"},{"issue":"3","key":"18264_CR44","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cancers12030766","volume":"12","author":"WN Goldsberry","year":"2020","unstructured":"Goldsberry, W. N. et al. Inhibiting WNT ligand production for improved immune recognition in the ovarian tumor microenvironment. Cancers 12(3), 766\u2013776 (2020).","journal-title":"Cancers"},{"issue":"11","key":"18264_CR45","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.7150\/thno.58390","volume":"11","author":"YT Liu","year":"2021","unstructured":"Liu, Y. T. & Sun, Z. J. Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics 11(11), 5365\u20135386 (2021).","journal-title":"Theranostics"},{"issue":"3","key":"18264_CR46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00262-014-1636-6","volume":"64","author":"J Landskron","year":"2014","unstructured":"Landskron, J. et al. Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. Cancer Immunol. Immunother.\/Cancer Immunol. Immunother. 64(3), 337\u2013347 (2014).","journal-title":"Cancer Immunol. Immunother.\/Cancer Immunol. Immunother."},{"key":"18264_CR47","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3389\/fimmu.2019.02453","volume":"10","author":"CM Paluskievicz","year":"2019","unstructured":"Paluskievicz, C. M. et al. T regulatory cells and priming the suppressive tumor microenvironment. Front. Immunol. 10, 2453 (2019).","journal-title":"Front. Immunol."},{"issue":"14","key":"18264_CR48","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/cells12141912","volume":"12","author":"K Ok\u0142a","year":"2023","unstructured":"Ok\u0142a, K. Myeloid-derived suppressor cells (MDSCs) in Ovarian cancer\u2014Looking back and forward. Cells 12(14), 1912\u20131922 (2023).","journal-title":"Cells"},{"issue":"9","key":"18264_CR49","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.7150\/ijbs.70013","volume":"18","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Suppressing MDSC infiltration in tumor microenvironment serves as an option for treating ovarian cancer metastasis. Int. J. Biol. Sci. 18(9), 3697\u20133713 (2022).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"18264_CR50","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41385-021-00382-x","volume":"14","author":"RRCE Schreurs","year":"2021","unstructured":"Schreurs, R. R. C. E. et al. Intestinal CD8+ T cell responses are abundantly induced early in human development but show impaired cytotoxic effector capacities. Mucosal Immunol. 14(3), 605\u2013614 (2021).","journal-title":"Mucosal Immunol."},{"issue":"11","key":"18264_CR51","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00262-020-02621-9","volume":"69","author":"JJ Wang","year":"2020","unstructured":"Wang, J. J. et al. Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression. Cancer Immunol. Immunother.\/Cancer Immunol. Immunother. 69(11), 2275\u20132289 (2020).","journal-title":"Cancer Immunol. Immunother.\/Cancer Immunol. Immunother."},{"issue":"10","key":"18264_CR52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5603\/GP.a2017.0098","volume":"88","author":"E Kebapc\u0131","year":"2017","unstructured":"Kebapc\u0131, E. et al. Outcomes of patients with advanced stage ovarian cancer with intestinal metastasis. Ginekol. Pol. 88(10), 537\u2013542 (2017).","journal-title":"Ginekol. Pol."},{"issue":"1","key":"18264_CR53","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s42003-023-05529-z","volume":"6","author":"DP Cook","year":"2023","unstructured":"Cook, D. P. et al. Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer. Commun. Biol. 6(1), 1152 (2023).","journal-title":"Commun. Biol."},{"issue":"1","key":"18264_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1078-0432.CCR-13-2063","volume":"20","author":"NL Gardi","year":"2014","unstructured":"Gardi, N. L., Deshpande, T. U., Kamble, S. C., Budhe, S. R. & Bapat, S. A. Discrete molecular classes of ovarian cancer suggestive of unique mechanisms of transformation and metastases. Clin. Cancer Res. 20(1), 87\u201399 (2014).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18264-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:04:30Z","timestamp":1759493070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18264-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18264"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18264-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval was taken from Institutional Review Board of NCCS with project identification code IEC\/22\/12\/2014 and Ethics Committee of the National Centre for Cell Science IEC\/22\/12\/2014 as mentioned in earlier publication (Kamble SC, Sen A, Dhake RD, Joshi AN, Divya Midha, Bapat SA. Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers. Journal of clinical medicine.8(3), 330\u20130 (2019)). Animal Ethics consent was given by NCCS Animal Experimentation Facility, Pune and mice experiments were done according to the guidelines provided by Institutional Animal Ethics Committee [IAEC; EAF\/2023\/B-436(I)].The present study is reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"34626"}}